Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Varicose Vein Treatment Market Outlook (2023 to 2033)

The global varicose vein treatment market size is poised to grow robustly from 2023 to 2033. According to the research report published by Future Market Insights, the global market is anticipated to exceed a valuation of US$ 765.2 million in 2023. It is estimated to clock a valuation of US$ 1,477.3 million by 2033. The market is foreseen to thrive at a CAGR of 6.8% from 2023 to 2033.

The rising prevalence of varicose veins and growing awareness about its various treatments are anticipated to boost the overall demand for varicose vein treatments.

Based on product, endovenous laser systems dominated the varicose vein treatment market with a share of about 52.47% in 2022, and it is expected to retain its dominance during the forecast period. This can be attributed to the rising popularity of laser therapy for treating vein disorders on account of its higher effectiveness and non-invasive nature.

Varicose veins, also referred to as varicosities or varicoses, are swollen or twisted veins that are typically blue or dark purple. Due to poor blood flow, varicose veins typically seem swollen and elevated, and patients often complain of pain.

Attribute Details
Market Share (2022) US$ 716.5 million
Market Share (2023) US$ 765.2 million
Market Share (2033) US$ 1,477.3 million
Market Share (2023 to 2033) 6.8%

Due to the increased strain on the lower body's veins when standing and walking upright, varicose veins often affect the legs and feet. Compression stockings should be worn for six months if treatment is required in the early stages, followed by ligation and stripping. Sclerotherapy or endothermal ablation can treat varicose veins if the pain persists or any problems are noted. Thus, a rise in the cases of vein disorders such as varicose veins, along with increasing awareness about the availability of various treatments, may continue to boost the growth of the varicose vein treatment market during the forecast period. Similarly, favorable government support and rapidly expanding healthcare industries, especially across developing regions, may bode well for market expansion.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Trends Driving the Market?

Development of Cost-effective Treatment Devices with Minimal Side Effects to Bolster Growth

Devices for endovenous laser (EVL) ablation are more frequently used for the treatment of varicose veins and are supported by substantial clinical research. However, endovenous laser operations are more expensive than other procedures like foam fillers, vein stripping, electrical blasting, and others. As a result, manufacturers are shifting their preference towards introducing cost-effective EVL devices that may reduce the cost of treatment procedures.

This may bode well for the market growth during the projected period. Similarly, usage of some endovenous laser ablation devices can lead to consequences like thrombophlebitis, nerve damage, burns, and deep vein thrombosis disorders. Manufacturers are developing novel devices that produce fewer complications to address this issue. These factors can generate lucrative opportunities for manufacturers and help grow the varicose vein treatment market.

Which are the Factors Restraining the Growth of the Market?

Although endovenous laser therapy is a simple and safe way to treat varicose veins, yet, the possibility of suffering from possible but rare side effects is not neglected. This treatment's most common side effect is aching and bruising at the puncture site, temporary numbness in the leg, or pain and inflammation in the length of the treated vein, which may stay for up to 2 weeks in some patients. Furthermore, skin discoloration and injury to neighboring tissues are experienced in some patients. This causes neuropraxia, i.e., pins and needles sensation or skin erythema and reddening in the leg.

There is also a possible risk of infection in the leg, deep vein thrombosis, or blood clot formation in most veins of the leg. Moreover, the alternative treatment options for varicose veins are restraining market growth. Besides laser therapy, many other medical procedures are available to treat varicose veins.

High ligation, vein stripping, and herbal remedies are being implemented to treat varicose veins across the globe. Thus, these factors may hamper the growth of the varicose vein treatment market in the near future.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Varicose Vein Treatment Market Historical Analysis (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)

The global varicose vein treatment industry size developed at a CAGR of 6.3% from 2018 to 2022. In 2018, the global market size stood at US$ 528.9 million. The market witnessed remarkable growth in the following years, accounting for US$ 716.5 million in 2022.

The rise in patients with varicose veins globally is driving the demand for treatments like endovenous laser therapy, eventually leading to the growth of the varicose vein treatment market.

Varicose veins are more prominent in females as compared to males. Increasing cases of varicose veins due to the aging population is a common problem across the globe. Apart from aging, lifestyle change can also lead to varicose veins.

Pregnant women are at high risk of varicose veins due to the baby causing increased pressure on the veins and partly due to hormones produced during pregnancy. Sometimes injury caused in a deep leg vein may also lead to varicose veins. Thus, rising cases of varicose veins may continue to expand the varicose vein treatment market size.

Similarly, the increasing prevalence of obesity across geographies is propelling the growth of the varicose vein treatment market. Fatness leads to issues related to blood circulation, which causes varicose veins. For instance, according to data presented by WHO, nearly 1 billion population is obese, including 650 million adults, 340 million teenagers, and 39 million children. This number is expected to increase further in the coming future, therefore, positively influencing varicose vein treatment.

Furthermore, the novel product launches, as well as an increase in the research and development spending by the key players in treatment devices, may further accelerate the growth of the market over the projected period.

Category-wise Insights

Which is the Most Popular Product in Varicose Vein Treatment?

Endovenous Laser Systems Remain the Highly Sought-After Product in the Market

Endovenous laser systems held a share of around 52.47% in the global market in 2022 and are expected to display a gradual growth rate over the forecast period. This can be attributed to the rising adoption of endovenous laser therapy for the treatment of varicose veins and other medical conditions due to its better effectiveness, non-invasive nature, and low risk of complications.

Which is the Leading End User of Varicose Vein Treatment Products?

Demand for Varicose Vein Treatment Products Remain High in Hospitals

The hospital segment held the leading market share of around 44.20% in the global varicose vein treatment market in 2022, and it is expected to retain its dominance during the forecast period.

A multidisciplinary strategy incorporating several medical disciplines, such as vascular surgery, interventional radiology, dermatology, and cardiology, may be necessary to treat varicose veins. Hospitals can provide comprehensive and coordinated care for individuals with varicose veins due to their wide variety of medical departments and experts. Hospitals are ahead of the curve in identifying promising avenues to improve healthcare delivery.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Why is the United States Considered a Dominant Market?

High Prevalence of Vein Disorders Fuelling Market Growth in the United States

The United States dominated the North America market for varicose vein treatment with a total market share of about 42.1% in 2022. The market is expected to witness impressive growth over the forecast period.

Key factors contributing to the United States market growth include the rise in cases of varicose veins, the presence of a highly developed healthcare system, and the availability of advanced medical devices.

Over the years, there has been a rapid surge in the cases of vein disorders like varicose veins in the United States. For instance, as per the Chicago Vein Institute, more than 40 million people in the United States suffer from varicose veins. This may continue to generate demand for varicose vein treatments in the country during the forecast period. Similarly, the heavy presence of leading market players, along with continuous new product launches and approvals, is positively impacting the market growth in the country. The United States is home to some leading medical device manufacturers constantly introducing new products to meet end-user demand.

For instance, in October 2021, a privately held company Venclose Inc. which concentrates on creative treatment processes for venous reflux disorders received FDA approval for a new radiofrequency ablation catheter, Venclose Maven. This catheter is used for the invasive treatment of incompetent perforated veins.

Additionally, due to the favorable reimbursement scenario, the United States population can get access to this treatment at an affordable cost. Thus, these factors are propelling the growth in the market in the United States.

What is the Demand Outlook for the Market in India?

Rising Awareness About Vein Varicose and Its Treatments Driving Market in India

As per FMI, the varicose vein treatment market in India is set to exhibit a CAGR of nearly 8.1% during the forecast period (2023 to 2033). In 2022, India captured 6.8% of global market shares. An increase in the patient pool and rising awareness about varicose veins and their treatments are key factors driving growth in the Indian market.

As per the report published by International Surgery Journal, 5% of the population is affected by a vascular disorder. The presence of this medical condition is particularly common among the geriatric population. Therefore, the increasing geriatric population and rising chronic diseases are expected to propel the market in India during the next ten years.

What Makes Germany a Lucrative Market in Varicose Vein Treatment?

Increasing Healthcare Spending Propelling Demand in Germany

Germany held a 6.3% share in the European market in 2022 and is projected to display a CAGR of 7.4% during the forecast period.

The developing healthcare infrastructure and increasing healthcare expenditure in Germany are propelling the market for varicose vein treatment. According to the report by The Federal Statistical Office, the healthcare expenditure of Germany was around EUR 67.9 billion in 2020, which shows an increase of 31.5% as compared to 2019.

Government transfers and subsidies in Germany financed healthcare expenditure. Thus, with the rise in patient awareness and increase in the disposable income of the population Germany is likely to show lucrative growth within the varicose vein market.

According to Future Market Insights, Country-wise Market Estimates are listed below:

Country Captured CAGR (2022)
United States 42.1%
United Kingdom 6.0%
China 7.1%
Japan 5.3%
India 6.8%

Competitive Landscape

Leading players in the market are adopting various organic and inorganic strategies such as new product launches and approvals, mergers, acquisitions, collaborations, and distribution agreements to expand their customer base and gain a competitive edge in the market.

Instances of key developmental strategies by the industry players in the market are given below:

  • THERACLION, a pioneering business creating a scalable robotic platform for non-invasive echotherapy, announced the release of SONOVEIN HD in May 2022. This innovative technology combines the first and only extracorporeal therapeutic ultrasound treatment with cutting-edge imaging capabilities from SuperSonic Imagine, a French company based in Aix-en-Provence that Hologic just purchased.
  • In April 2022, I-VASC, a medical device company based in Italy, closed a Series A investment worth EUR 1.8 million to bring up its VELEX device, which is used for the treatment of varicose veins.
  • The second version of SONOVEIN, THERACLION's HIFU therapy option for varicose veins, received the CE Mark in October 2020.

Key Players in the Global Market

  • AngioDynamics Inc.
  • Medtronic
  • Syneron Medical Ltd.
  • Alma Lasers Ltd.
  • Alna-Medicalsystem GmbH
  • LSO Medical
  • WON TECH Co. Ltd.
  • Intros Medical Laser GmbH
  • Energist Ltd.
  • Dornier Medtech GmbH
  • Theraclion
  • I-VASC

Scope of the Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ million for Value
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)
Key Countries Covered
  • United States
  • Canada
  • Germany
  • United Kingdom
  • Nordic
  • Russia
  • BENELUX
  • Poland
  • France
  • Spain
  • Italy
  • Czech Republic
  • Hungary
  • Rest of EMEAI
  • Brazil
  • Peru
  • Argentina
  • Mexico
  • South Africa
  • Northern Africa
  • GCC Countries
  • China
  • Japan
  • South Korea
  • India
  • ASEAN
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand
  • Others
Key Segments Covered
  • Product
  • End-user
  • Region
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Market Segmentation

By Product:

  • Endovenous Laser Systems
    • Diode Lasers
    • YAG Lasers
  • Endovenous Laser Fibres
    • Bare Tip Laser Fibres
    • Radial Tip Laser Fibers
    • Gold Tip Laser Fibres
  • Treatment Method
    • Non-thermal Ablation
    • Radiofrequency Ablation
    • Sclerotherapy

By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialized Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How big is this market?

This market is valued at US$ 765.2 million in 2023.

Who are the Key Market Players?

AngioDynamics Inc., Medtronic, and Syneron Medical Ltd. are key market players.

Which is the Key Segment by Product Type?

The endovenous laser systems is likely to remain preferred in 2022.

What is the contribution of the United States in the market?

The United States held 42.1% of the global market share in 2022.

How Big will be the Market by 2033?

The market is estimated to reach US$ 1,477.3 million by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Laser Systems

            5.3.1.1. Diode Lasers

            5.3.1.2. YAG Lasers

        5.3.2. Laser Fibres

            5.3.2.1. Bare Tip

            5.3.2.2. Radial Tip

            5.3.2.3. Gold Tip

        5.3.3. Treatment Method

            5.3.3.1. Non-thermal Ablation

            5.3.3.2. Radiofrequency Ablation

            5.3.3.3. Sclerotherapy

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Ambulatory Surgical Centres

        6.3.3. Specialised Clinics

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Product

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Product

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product

            15.5.2.2. By End User

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Product

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Product

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Product

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. AngioDynamics, Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Medtronic

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Syneron Medical Ltd

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Alma Lasers Ltd.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Alna-Medicalsystem GmbH

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. LSO Medical

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. WON TECH Co., Ltd

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. intros Medical Laser GmbH

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Energist Ltd

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Dornier Medtech GmbH

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

        17.1.11. Theraclion

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

        17.1.12. I-VASC

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Vein Finder Market

Published : March 2024

Healthcare

IV Therapy and Vein Access Devices Market

Published : June 2022

Explore Healthcare Insights

View Reports

Varicose Vein Treatment Market